Korean Health Stocks' Rising Valuations Worrying: Dalton

The video discusses the Korean market's high valuations, driven by strong momentum and a short selling ban. It highlights concerns about a potential bubble, especially in the healthcare sector, due to COVID-19 stock surges. The polarization in the market is noted, with biotech, internet, and EV sectors thriving while others suffer. The impact of the short selling ban and potential triggers for market correction are explored. Additionally, the video addresses corporate governance improvements in Korea and the persistent Korea discount, suggesting that investors should monitor these changes.

How might the success of COVID-19 treatment manufacturers impact the market?

What is the significance of the 'Korea discount' mentioned in the text?

What changes in corporate governance are being observed in South Korea?